Overview

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
0
Participant gender:
All
Summary
The trial is a double-blinded randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi (golimumab) among patients with PsA who have an inadequate response to a TNFi.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Janssen Scientific Affairs, LLC
Treatments:
Golimumab
Criteria
Inclusion Criteria:

1. Psoriatic arthritis meeting CASPAR criteria;

2. Active psoriatic arthritis defined by the presence of at least 2 swollen joints OR 1
swollen joint and 1 site of active enthesitis OR active dactylitis involving 2 joints

3. At least one active psoriasis plaque;

4. Using a TNFi or previously used a single TNFi historically and either never responded
or lost response (TNF IR) and planning to switch to a new biologic therapy;

5. If using a single oral small molecule/csDMARD (i.e., methotrexate, leflunomide,
hydroxycloroquine, sulfasalazine, or apremilast), must be on a stable dose for 4 weeks
and remain on a stable dose during the study; Only use of a single OSM/csDMARD is
allowed.

6. If using NSAIDs, glucocorticoids (<10 mg daily) or topical medications for psoriasis,
must be on a stable dose for 4 weeks and remain on a stable dose during the study;

7. age 18-80

Exclusion Criteria:

1. Prior exposure to golimumab or another non-TNFi biologic (IL12/23i, JAKi, an IL17i, or
an IL23i);

2. An adverse event that precludes use of another TNFi (development of drug-induced SLE,
allergic reaction, serious infection, heart failure symptoms, demyelination at any
point during use of therapy) or any other contraindication or substantial intolerance
to a TNFi;

3. Use of moderate to high dose glucocorticoids (>10 mg).

4. Already meet the primary outcome at screening or baseline

5. Currently pregnant or actively trying to conceive